AnaptysBio, Inc. (ANAB) Tops Q4 EPS by 4c

AnaptysBio, Inc. (NASDAQ: ANAB) reported Q4 EPS of ($1.59), $0.04 better than the analyst estimate of ($1.63). Revenue for the quarter came in at $0 versus the consensus estimate of $3.83 million.

For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BMO starts chip stocks coverage: Here are its preferred picks
• CoStar Group acquires Zonda for $800M, adding new home data